◆ 会议时间：2023年4月24日至26日
◆ 会议地点：日本 福冈

◆ 会议简介：

2023年第67届日本风湿病学会(JCR)年会将于2023年4月24日至26日在日本福冈举行，会议由日本风湿病学会(JCR)主办。

日本风湿病学会(JCR)成立于1957年，日本所有主要科学和医院机构的执业医师、研究科学家和学术学者中，有9964人是日本风湿病学会(JCR)的成员。JCR的宗旨是通过分享风湿病发病机制的知识，来减轻个人和社会对风湿病的负担，从而改善风湿病的治疗、预防和康复。JCR每年春季举办年度科学会议，为风湿病学家和其他专家宣提供一个分享风湿性疾病预防和治疗知识人平台；JCR还举办国际风湿病学研讨会，组织区域教育课程以及先进的讲座等等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

JCR 2023
第67回日本リウマチ学会総・学術集会
67th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology

摘要征集时间：

2022年9月14日至10月31日

Welcome Message

The 67th Annual Scientific Meeting of the Japan College of Rheumatology will be held in Fukuoka City for three days from April 24 to 26, 2023. It is a great honor for me to serve as the president for this meeting, and I wish to thank all concerned for your support and cooperation. Although the world has been profoundly destabilized by disasters such as the COVID-19 pandemic and the Russian invasion, as of the time of writing in March 2022, this event will be held in person in Fukuoka City. In view of maximal anti-infection measures, we are considering to accommodate some online activities as well.

The 21st century has seen revolutionary changes in the treatment of rheumatoid arthritis and spondylarthritis. It has been 20 years since biological preparations were first marketed in 2003, and 10 years since JAK inhibitors entered the market in 2013. It has become possible to induce remission and prevent further structural damage of the joints in most patients. We are however facing new issues, including the short-and long-term safety and economic efficiency of these drugs, COVID-19-related medical handling of patients, handling of refractory cases, treatment of organ damage, post-remission drug discontinuation, and the appropriate use of molecular-targeted agents. I trust that this meeting will serve as the base where we discuss and propose increasingly innovative and advanced therapeutic strategies supported by globally highly valued post-marketing surveillance and systematic registries established by this college, ahead of all other countries in the world.

Although it has become possible to use molecular targeted therapeutic agents for the treatment of systemic autoimmune and connective tissue diseases like systemic lupus erythematosus and large/small vessel vasculitic syndromes, we have not been able to reach the therapeutic targets for organ damage and the inhibition of recurrence, and many unmet needs are remaining. It is a pressing issue to investigate the concerned pathologies and develop molecular-targeted agents by mechanism- and pathology-based approach. I believe that this meeting, solidly rooted in a globally unparalleled cooperative system involving interdisciplinary collaboration between those involved in basic research and clinical application, internal medicine and orthopedic surgery, pediatric and geriatric medicine, spanning all levels from interns to veterans, etc. – the strength of the Japan College of Rheumatology – can serve as the starting point for new developments that will form the foundation for original themes and concepts.

This meeting will also have a strong focus on the promotion of internationalization utilizing Japan’s uniqueness and characteristics, featuring various joint sessions with ACR, APLAR, and EULAR. It is essential to procure young power, both domestic and overseas, to surmount most issues, and we will use the website and SNS to attract young researchers in- and outside Japan to join the meetings.

The theme of this meeting is “With Sincerity, go above and beyond” The picturesque original Japanese saying provoking the image of “heaven being moved by total sincerity” is an adaptation of a quote by the Japanese 19th century scholar Shoin Yoshida, which in turn originated with the legendary words of the Chinese Confucian philosopher Mencius expressing the sentiment that “if one is truly sincere in what one does, there is nobody one will not be able to move.” If one truly puts one’s whole heart into whatever you do, be it education, clinical practice or research, one can look forward to reaping benefits in the future.

I hope that new and positive expectations for the future will take root at this meeting, despite our present unstable social circumstances. Thank you for your support of and cooperation with these endeavors.

The 67th Annual Scientific Meeting of the Japan College of Rheumatology
President: Yoshiya Tanaka
Professor and Chairman, The First Department of Internal Medicine, School of Medicine,
University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

注册费：

Registration Fee

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。